Top compounds associated with response to CLDND2


Feature Type Standardized
Nominal ANOVA
mRNA itraconazole CTRPv2 pan-cancer AAC 0.047 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC -0.088 0.2
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA regorafenib CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.065 0.2
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.045 0.2
mRNA gossypol CTRPv2 pan-cancer AAC -0.044 0.2
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.054 0.2
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.055 0.2
Download CSV